Identification of Molds with Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry: Performance of the Newly Developed MSI-2 Application in Comparison with the Bruker Filamentous Fungi Database and MSI-1.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
20 09 2021
Historique:
pubmed: 29 7 2021
medline: 26 10 2021
entrez: 28 7 2021
Statut: ppublish

Résumé

Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) represents a promising tool for the rapid and efficient identification of molds, but improvements are still necessary to achieve satisfactory results when identifying cryptic species. Here, we aimed to validate a new web application, MSI-2, which replaces MSI-1, an application that was built and deployed online in 2017. For the evaluation, we gathered 633 challenging isolates obtained from daily hospital practice that were first identified with DNA-based methods, and we submitted their corresponding mass spectra to three identification programs (Bruker, MSI-1, and MSI-2). The MSI-2 application had a better identification performance at the species level than MSI-1 and Bruker, reaching 83.25% correct identifications, compared with 63.19% (MSI-1), 38.07% (Bruker with a 1.7 threshold), and 21.8% (Bruker with a 2.0 threshold). The MSI-2 application performed especially well for Aspergillus and Fusarium species, including for many cryptic species, reaching 90% correct identifications for Aspergillus species and 78% for Fusarium species compared to 69% and 43% with MSI-1. Such an improvement may have a positive impact on patient management by facilitating the identification of cryptic species potentially associated with a specific antifungal resistance profile.

Identifiants

pubmed: 34319807
doi: 10.1128/JCM.01299-21
pmc: PMC8451417
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0129921

Références

Antimicrob Agents Chemother. 2020 Nov 17;64(12):
pubmed: 32900686
Persoonia. 2019;43:1-47
pubmed: 32214496
Med Mycol. 2018 Jul 1;56(5):602-609
pubmed: 29420802
J Clin Microbiol. 2020 Nov 18;58(12):
pubmed: 32938733
J Clin Microbiol. 2014 Aug;52(8):2797-803
pubmed: 24850347
J Clin Microbiol. 2017 Sep;55(9):2661-2670
pubmed: 28637907
Emerg Microbes Infect. 2016 Dec 7;5(12):e124
pubmed: 27924809
Med Mycol. 2019 Nov 1;57(8):962-968
pubmed: 30690478
mSphere. 2020 Sep 16;5(5):
pubmed: 32938701
J Appl Microbiol. 2021 Jan;130(1):278-291
pubmed: 32650353
Clin Microbiol Infect. 2019 Jul;25(7):892-897
pubmed: 30394360
BMC Microbiol. 2017 Jan 31;17(1):25
pubmed: 28143403
Stud Mycol. 2020 Jun 27;95:5-169
pubmed: 32855739
Mycopathologia. 2020 Jun;185(3):515-525
pubmed: 32506392
J Microbiol Immunol Infect. 2021 Mar 29;:
pubmed: 33839057
J Vet Diagn Invest. 2019 May;31(3):471-474
pubmed: 30943879
J Clin Microbiol. 2008 Aug;46(8):2477-90
pubmed: 18524963
J Fungi (Basel). 2021 Mar 25;7(4):
pubmed: 33806102
Med Mycol. 2015 May;53(4):313-37
pubmed: 25802363
Med Mycol. 2021 Jan 4;59(1):81-86
pubmed: 32437532
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32312779
Front Microbiol. 2019 Jul 18;10:1647
pubmed: 31379792

Auteurs

Anne-Cécile Normand (AC)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.

Marion Blaize (M)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et des Maladies Infectieuses, Paris, France.

Sébastien Imbert (S)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
CHU de Bordeaux, Groupe Hospitalier Pellegrin, Service de Mycologie, Bordeaux, France.

Ann Packeu (A)

Sciensano, BCCM/IHEM Collection, Mycology and Aerobiology Unit, Brussels, Belgium.

Pierre Becker (P)

Sciensano, BCCM/IHEM Collection, Mycology and Aerobiology Unit, Brussels, Belgium.

Arnaud Fekkar (A)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et des Maladies Infectieuses, Paris, France.

Dirk Stubbe (D)

Sciensano, BCCM/IHEM Collection, Mycology and Aerobiology Unit, Brussels, Belgium.

Renaud Piarroux (R)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH